Announcements Trials
Browse Landscape

Phase

Phase 3 14Phase 2 7Phase 4 5Phase NA 4Phase 1 4Phase 1/2 2Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 699Breast Neoplasms 629Neoplasms 582Leukemia, Myeloid, Acute 481Colorectal Neoplasms 455Multiple Myeloma 444Melanoma 424Prostatic Neoplasms 383Neoplasm Metastasis 370Pancreatic Neoplasms 361Recurrence 347Lymphoma 340Ovarian Neoplasms 322Lung Neoplasms 297Lymphoma, Non-Hodgkin 295Leukemia 287Glioblastoma 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Stomach Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 235Carcinoma, Hepatocellular 231Squamous Cell Carcinoma of Head and Neck 219Lymphoma, Large B-Cell, Diffuse 217Myelodysplastic Syndromes 212Carcinoma, Renal Cell 210Lymphoma, Follicular 183Head and Neck Neoplasms 172Brain Neoplasms 169Triple Negative Breast Neoplasms 167Lymphoma, Mantle-Cell 167

Interventions

Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Psoriasis × Clear all
NCT00585650 2023-08-18

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

University of California, Irvine

Phase 1/2 Completed
20 enrolled 5 charts

Psoriasis

NCT00129415 2015-05-22

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

University of Michigan

Phase 1/2 Terminated
28 enrolled
DermatologicLymphoid

Alopecia, Dermatitis, Atopic, Mycosis Fungoides, Psoriasis, Skin Diseases, Urticaria, Lymphoma, T-Cell, Cutaneous, Striae Distensae

Data powered by HemOnc (CC BY 4.0) Colophon âš¡